Therapy Areas: Oncology
15 October 2021 - - The US Food and Drug Administration has approved Keytruda, US-based pharmaceutical company Merck's (NYSE: MRK) anti-PD-1 therapy, in combination with chemotherapy, with or wit...
15 October 2021 - - The first patient has been dosed in US-based cancer immunotherapy company Immune-Onc Therapeutics, Inc's first-in-human clinical trial of IO-108, a novel antagonist antibody t...
15 October 2021 - - US-based life science company Agilent Technologies Inc's (NYSE: A) Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early b...
15 October 2021 - - Germany-based Abalos Therapeutics has extended its series A funding round bringing the total raised in this round to EUR 43m (USD 50m), the company said.

The exte...
15 October 2021 - - The US Food and Drug Administration has approved Keytruda, US-based pharmaceutical company Merck's (NYSE: MRK) anti-PD-1 therapy, in combination with chemotherapy, with or wit...
15 October 2021 - - US-based clinical-stage company Tizona Therapeutics, Inc's lead investigational therapy, TTX-080, a novel antibody targeting HLA-G, has advanced to Phase 1b, the company said....
Related Headlines